研報掘金丨申萬宏源:亞鉀國際未來成長邏輯清晰,維持“增持”評級
申萬宏源研究指出,打通一體化泛資源佈局,實力股東賦能亞鉀國際(000893.SZ)長期發展。匯能集團是中國民營煤炭行業領軍企業,連續多年穩居中國民營企業500強前列。根據轉讓協議,匯能集團明確支持中農集團保留原有董事席位,並約定亞鉀國際國內50%鉀肥銷量優先通過中農渠道分銷,有望依託集團在煤炭開採和煤化工產業領域積累的人才資源和技術力量,助力公司“資本+資源+渠道”的聯動模式。後續來看,公司有望實現500萬噸/年鉀肥產銷規模,並將根據市場需求進一步擴建至700-1000萬噸/年體量,未來成長邏輯清晰。維持“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.